SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
复制标题
DOI：
10.1016/j.isci.2023.108302
复制
发表时间：
2023
期刊：
影响因子：
5.8
通讯作者：
Yongmei Yin
中科院分区：
文献类型：
--
作者：
Jie Mei;Ziyi Fu;Yun Cai;Chenghu Song;Jiaofeng Zhou;Yichao Zhu;Wenjun Mao;Junying Xu;Yongmei Yin
